Review

Henry Meds tirzepatide review

$5,388 a year, all in. That is $3,888 more than the cheapest option. Sublingual and oral formats.

Illustration of bottles and boxes lined up on a shelf

Recorded article date: 2026-09-18 · Editorial notes revised 2026-11-07

This article retains historical comparison material. Its record date is not a current offer check. Selected newer reviews have their own dates and limits; consult those reviews and the applicable written terms before comparing a purchase.

Henry Meds charges no membership fee, then prices injectable tirzepatide at $449 a month — about $5,388 a year, the dearest compounded programme in our table.

The first month is $399 and renewals are $449. The company advertises that pricing "starts at $179 a month", which is true of its sublingual tier and not of the weekly injection most readers are picturing. Those are different products at different prices.

The yearly bill

Historical comparison: saved figures with their record dates. Monthly figures may be equivalents; multiplying by twelve models an unchanged input, not a confirmed annual bill. Publisher-selected placement differs from numerical order.
Henry Meds · tirzepatide
Advertised from$399/mo
Membership on topNone
What you actually pay$449/mo
Over twelve months$5,388
Versus the cheapest option+$3,888 a year
Cheapest-first position20 of 20

No separate membership, but the recurring injection price is the highest in this comparison.

Where the money goes

The absence of a membership is genuinely good practice, and it is worth saying that Henry is not hiding anything — the prices are published. It simply charges more for the medication than anyone else here. Multi-month blocks do bring it down: three months of oral tirzepatide is $1,047, or $891 paid up front.

Compounded GLP-1 provider with a strong oral and sublingual line alongside weekly injections, sold in monthly and prepaid multi-month blocks.

What the same money buys elsewhere

This older comparison paragraph used saved figures. Before making a new comparison, consult the November 7 MEDVI tirzepatide review and assemble complete offers for the same intended period.

Historical comparison: saved figures with their record dates. Monthly figures may be equivalents; multiplying by twelve models an unchanged input, not a confirmed annual bill. Publisher-selected placement differs from numerical order.
ProgrammeRecorded monthly figureRecorded figure × 12Difference from stored minimum × 12Record date
Coreage Rx Paid first placement
Recorded membership: $0		$199$2,388+$8882026-10-04
SuperHealthy Rx Publisher-selected placement
Recorded membership: $0		$135$1,620+$1202026-10-04
Likeness Rx Publisher-selected placement
Recorded membership: $0		$199$2,388+$8882026-10-04
Trimi
Recorded membership: $0		$125$1,500—2026-09-18
Ozari Health
Recorded membership: $0		$125$1,500—2026-09-18
Fifty 410
Recorded membership: $0		$133$1,596+$962026-09-18

Is the extra worth it?

One scenario justifies it: you will not inject. Henry has the deepest oral and sublingual range here, and if a tablet or a sublingual drop is the difference between taking the medication and not taking it, the premium is beside the point.

What we checked

  • Injectable tirzepatide listed at $399 for the first month and $449/month recurring.
  • Oral tirzepatide tablets listed at $299 first month, $349/month recurring.
  • Compounded semaglutide injection around $297/month; sublingual around $249/month with a $179/month tier.
  • Three-month oral tirzepatide supply $1,047, or $891 paid in full.
  • Three-month oral semaglutide supply $747, or $537 paid in full.
  • Advertising states pricing "starts at $179/month", which corresponds to the lowest sublingual tier.

Verified 2026-09-18. Prices in this market move, so treat anything older than a month as a starting point rather than a quote.

The good

  • No membership fee layered on top of medication.
  • Real choice of sublingual, oral tablet and injection.
  • Discounts for paying a multi-month block up front.

The bad

  • Recurring injectable tirzepatide at $449/month is the most expensive compounded option here.
  • The "$179" and "$297" figures describe different products, which readers routinely conflate.
  • Month one and month two prices differ by $50.

Watch for this at checkout. The advertised "starts at $179" is the sublingual tier. Weekly injectable tirzepatide renews at $449/month.

Verdict

Buy the oral or sublingual products here. For the weekly injection you are paying roughly double the cheapest option for the same class of medication.

Full workings for every programme are in the cheapest tirzepatide programmes, and our scoring is explained on how we rate.

Read next

Coreage Rx tirzepatide review$2,388 a year, all in. That is $888 more than the cheapest option. Best overall on true monthly cost.Likeness Rx semaglutide review$1,668 a year, all in. That is $648 more than the cheapest option. Public offer; not independently scored.Trimi tirzepatide review$1,500 a year, all in. The cheapest option in our table. Lowest flat price with named pharmacies.Comparing tirzepatide costs and commitmentsA historical comparison table and a practical way to compare upfront payments, renewal assumptions and supply periods.How to cut your GLP-1 billSeven checks that routinely save $1,000 or more a year on exactly the same prescription.

CoreAge Rx pays us a commission on sign-ups through our links and pays for the first position in our price tables where included. How we rate · Disclosure